Pittenger & Anderson Inc’s DexCom DXCM Stock Holding History

Pittenger & Anderson Inc’s Portfolio DXCM Stock Details DXCM Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q2	–	Sell	-2,853	Closed	-$396K	–	449
2024 Q1	$396K	Buy	2,853 +40	+1%	+$5.03K	0.02%	191
2023 Q4	$349K	Buy	+2,813	New	+$287K	0.02%	194
2023 Q3	–	Sell	-120	Closed	-$15.4K	–	437
2023 Q2	$15.4K	Hold	120	–	–	﹤0.01%	334
2023 Q1	$13.9K	Buy	120 +59	+97%	+$6.6K	﹤0.01%	334
2022 Q4	$6.91K	Hold	61	–	–	﹤0.01%	360
2022 Q3	$5K	Buy	61 +25	+69%	+$2.12K	﹤0.01%	373
2022 Q2	$3K	Hold	36	–	–	﹤0.01%	397
2022 Q1	$5K	Hold	36	–	–	﹤0.01%	379
2021 Q4	$5K	Hold	36	–	–	﹤0.01%	392
2021 Q3	$5K	Buy	36 +8	+29%	+$1.01K	﹤0.01%	392
2021 Q2	$3K	Hold	28	–	–	﹤0.01%	376
2021 Q1	$3K	Buy	28 +8	+40%	+$751	﹤0.01%	362
2020 Q4	$2K	Hold	20	–	–	﹤0.01%	352
2020 Q3	$2K	Buy	+20	New	+$2.09K	﹤0.01%	344

Other funds holding DXCM

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Sands Capital Management Arlington, Virginia $25.5B AUM 26.46% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Pittenger & Anderson Inc's DXCM Position: Q2 2024 in Review

Pittenger & Anderson Inc sold out of DexCom (DXCM) in Q2 2024, closing a stake of 2,853 shares — an estimated $396K sold.

Pittenger & Anderson Inc first reported a position in DXCM in Q3 2020 and held it in 14 quarters. The position peaked at $396K in Q1 2024. 999 funds tracked by Wall St. Rank hold DXCM as of Q2 2024.

Pittenger & Anderson Inc reported no remaining DexCom position as of Q2 2024 after selling out during the quarter.
Pittenger & Anderson Inc sold 2,853 DexCom shares in Q2 2024, an estimated $396K.
Pittenger & Anderson Inc first reported a position in DexCom in Q3 2020 and held it in 14 quarters.
Pittenger & Anderson Inc's DexCom position peaked at $396K in Q1 2024.
999 funds tracked by Wall St. Rank held DexCom as of Q2 2024.

Based on Pittenger & Anderson Inc's 13F filing for Q2 2024, filed 9 Aug 2024.